These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18996078)

  • 1. Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease.
    Augustin S; Rimbach G; Augustin K; Schliebs R; Wolffram S; Cermak R
    Arch Biochem Biophys; 2009 Jan; 481(2):177-82. PubMed ID: 18996078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginkgo biloba extract and its flavonol and terpenelactone fractions do not affect beta-secretase mRNA and enzyme activity levels in cultured neurons and in mice.
    Augustin S; Huebbe P; Matzner N; Augustin K; Schliebs R; Cermak R; Wolffram S; Rimbach G
    Planta Med; 2008 Jan; 74(1):6-13. PubMed ID: 18186016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind).
    Sabbagh MN; Walker DG; Reid RT; Stadnick T; Anand K; Lue LF
    Neurosci Lett; 2008 Dec; 448(2):217-20. PubMed ID: 18926877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease.
    Tabuchi M; Yamaguchi T; Iizuka S; Imamura S; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2009 Feb; 122(1):157-62. PubMed ID: 19146938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis.
    Bjelik A; Bereczki E; Gonda S; Juhász A; Rimanóczy A; Zana M; Csont T; Pákáski M; Boda K; Ferdinandy P; Dux L; Janka Z; Sántha M; Kálmán J
    Neurochem Int; 2006 Sep; 49(4):393-400. PubMed ID: 16546298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
    Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
    Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse.
    Wan W; Zhang C; Danielsen M; Li Q; Chen W; Chan Y; Li Y
    Exp Gerontol; 2016 Aug; 81():92-100. PubMed ID: 27220811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease.
    Wolf SA; Kronenberg G; Lehmann K; Blankenship A; Overall R; Staufenbiel M; Kempermann G
    Biol Psychiatry; 2006 Dec; 60(12):1314-23. PubMed ID: 16806094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts.
    Colciaghi F; Borroni B; Zimmermann M; Bellone C; Longhi A; Padovani A; Cattabeni F; Christen Y; Di Luca M
    Neurobiol Dis; 2004 Jul; 16(2):454-60. PubMed ID: 15193301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease.
    Thomas P; Wang YJ; Zhong JH; Kosaraju S; O'Callaghan NJ; Zhou XF; Fenech M
    Mutat Res; 2009 Feb; 661(1-2):25-34. PubMed ID: 19027755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment.
    Stackman RW; Eckenstein F; Frei B; Kulhanek D; Nowlin J; Quinn JF
    Exp Neurol; 2003 Nov; 184(1):510-20. PubMed ID: 14637120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice.
    Cachard-Chastel M; Lezoualc'h F; Dewachter I; Deloménie C; Croes S; Devijver H; Langlois M; Van Leuven F; Sicsic S; Gardier AM
    Br J Pharmacol; 2007 Apr; 150(7):883-92. PubMed ID: 17325649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer's disease.
    Liu X; Hao W; Qin Y; Decker Y; Wang X; Burkart M; Schötz K; Menger MD; Fassbender K; Liu Y
    Brain Behav Immun; 2015 May; 46():121-31. PubMed ID: 25637484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice.
    Ozmen L; Albientz A; Czech C; Jacobsen H
    Neurodegener Dis; 2009; 6(1-2):29-36. PubMed ID: 19066434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
    Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
    J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistological evidences of Ginkgo biloba extract altering Bax to Bcl-2 expression ratio in the hippocampus and motor cortex of senescence accelerated mice.
    Mak YT; Chan WY; Lam WP; Yew DT
    Microsc Res Tech; 2006 Aug; 69(8):601-5. PubMed ID: 16721734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.